Selective radiosensitization by nitric oxide in tumor cell lines

Cancer Letters

Volumn 248, Issue 1, 2007, Pages 123-130

  Policastro, Lucía ^a,b   Duran, Hebe ^a,b,c   Henry, Yann ^d   Molinari, Beatriz ^a,b   Favaudon, Vincent ^d  

^a DEPARTAMENTO DE FÍSICA   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c UNIVERSIDAD NACIONAL DE SAN MARTÍN   (Argentina)

^d INSERM   (France)

Author keywords

Nitric oxide; Radiosensitization; Tumor cells

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; NITRIC OXIDE; RADIOSENSITIZING AGENT;

ANIMAL CELL; ARTICLE; C57BL MOUSE; CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; DISEASE SEVERITY; EVALUATION; GAMMA IRRADIATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; RADIOSENSITIZATION;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; GAMMA RAYS; HUMANS; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE DONORS; TRIAZENES;

EID: 33847249098     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.06.009     Document Type: Article

References (47)

1. Kvols L.K. Radiation sensitizers: a selective review of molecules targeting DNA and non-DNA targets. J. Nucl. Med. 46 (2005) 187S-190S
2. Xu W., Liu L.Z., Loizidou M., Ahmed M., and Charles I.G. The role of nitric oxide in cancer. Cell Res. 12 (2002) 311-320
3. Li C.Q., and Wogan G.N. Nitric oxide as a modulator of apoptosis. Cancer Lett. 226 (2005) 1-15
4. Brune B. Nitric oxide: NO apoptosis or turning it on?. Cell Death Differ. 10 (2003) 864-869
5. Mitchell J.B., Wink D.A., DeGraff W., Gamson J., Keefer L.K., and Krishna M.C. Hypoxic mammalian cell radiosensitization by nitric oxide. Cancer Res. 53 (1993) 5845-5848
6. Griffin R.J., Makepeace C.M., Hur W.J., and Song C.W. Radiosensitization of hypoxic tumor cells in vitro by nitric oxide. Int. J. Radiat. Oncol. Biol. Phys. 36 (1996) 377-383
7. Janssens M.Y., Verovski V.N., Van den Berge D.L., Monsaert C., and Storme G.A. Radiosensitization of hypoxic tumour cells by S-nitroso-N-acetylpenicillamine implicates a bioreductive mechanism of nitric oxide generation. Br. J. Cancer 79 (1999) 1085-1089
8. Janssens M.Y., Van den Berge D.L., Verovski V.N., Monsaert C., and Storme G.A. Activation of inducible nitric oxide synthase results in nitric oxide-mediated radiosensitization of hypoxic EMT-6 tumor cells. Cancer Res. 58 (1998) 5646-5648
9. Verovski V.N., Van den Berge D.L., Soete G.A., Bols B.L., and Storme G.A. Intrinsic radiosensitivity of human pancreatic tumour cells and the radiosensitising potency of the nitric oxide donor sodium nitroprusside. Br. J Cancer 74 (1996) 1734-1742
10. Kurimoto M., Endo S., Hirashima Y., Hamada H., Ogiichi T., and Takaku A. Growth inhibition and radiosensitization of cultured glioma cells by nitric oxide generating agents. J. Neurooncol. 42 (1999) 35-44
11. Quintanilla M., Haddow S., Jonas Jaffe D., Bowden G.T., and Balmain A. Comparison of ras activation during epidermal carcinogenesis in vitro and in vivo. Carcinogenesis 12 (1991) 1875-1881
12. Díaz-Guerra M., Haddow S., Bauluz C., Jorcano J.L., Cano A., Balmain A., and Quintanilla M. Expression of simple epithelial cytokeratins in mouse epidermal keratinocytes harboring Harvey ras gene alterations. Cancer Res. 52 (1992) 680-687
13. Larcher F., Robles A.I., Durán H., Murillas R., Quintanilla M., Cano A., Conti C.J., and Jorcano J.L. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Res. 56 (1996) 5391-5396
14. Yuspa S.H., Morgan D., Lichti U., Spangler E.F., Michael D., Kilkenny A., and Hennings H. Cultivation and characterization of cells derived from mouse skin papillomas induced by an initiation-promotion protocol. Carcinogenesis 7 (1986) 949-958
15. Conti C.J., Fries J.W., Viaje A., Miller D.R., Morris R., and Slaga T.J. In vivo behavior of murine epidermal cell lines derived from initiated and noninitiated skin. Cancer Res. 48 (1996) 435-439
16. Gaffney E.V. A cell line (HBL-100) established from human breast milk. Cell Tissue Res. 227 (1982) 563-568
17. Loberg L.I., Gauger J.R., Buthod J.L., Engdahl W.R., and McCormick D.L. Gene expression in human breast epithelial cells exposed to 60 Hz magnetic fields. Carcinogenesis 20 (1999) 1633-1636
18. Soule H.D., Vazguez J., Long A., Albert S., and Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51 (1973) 1409-1416
19. Hamburger A.W., and Salmon S.E. Primary bioassay of human tumor stem cells. Science 197 (1977) 461-463
20. Giovanella B.C., Stehlin J.S., and Williams Jr. L.J. Heterotransplantation of human malignant tumors in "nude" thymusless mice. II. Malignant tumors induced by injection of cell cultures derived from human solid tumors. J. Natl. Cancer Inst. 52 (1974) 921-930
21. Soule H.D., and McGrath C.M. Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice. Cancer Lett. 10 (1980) 177-189
22. Keefer L.K., Nims R.W., Davies K.M., and Wink D.A. "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol. 268 (1996) 281-293
23. Wang Z., Cook T., Alber S., Liu K., Kovesdi I., Watkins S.K., Vodovotz Y., Billiar T.R., and Blumberg D. Adenoviral gene transfer of the human inducible nitric oxide synthase gene enhances the radiation response of human colorectal cancer associated with alterations in tumor vascularity. Cancer Res. 64 (2004) 1386-1395
24. Policastro L., Molinari B., Larcher F., Blanco P., Podhajcer O.L., Costa C.S., Rojas P., and Durán H. Imbalance of antioxidant enzymes on tumor cells and inhibition of proliferation and malignant features by scavenging hydrogen peroxide. Mol. Carcinog. 39 (2004) 103-113
25. Henle E.S., and Linn S. Formation, prevention and repair of DNA damage by iron/hydrogen peroxide. J. Biol. Chem. 272 (1997) 19095-19098
26. Szumiel I. Monitoring and signaling of radiation-induced damage in mammalian cells. Radiat. Res. 150 (1998) S92-S101
27. Pirollo K., Tong Y., Villegas Z., Chen Y., and Chang E. Oncogene-transformed NIH 3T3 cells display radiation resistance levels indicative of a signal transduction pathway leading to the radiation resistance phenotype. Radiat. Res. 135 (1993) 234-243
28. Buchmann A., Ruggeri B., Klein-Szanto A.J.P., and Balmain A. Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7. Cancer Res. 51 (1991) 4097-4101
29. Bremner R., and Balmain A. Genetic changes in skin tumor progression: correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell 61 (1990) 407-417
30. Bianchi A., Aldaz C.M., and Conti C.J. Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors. Proc. Natl. Acad. Sci. USA 87 (1990) 6902-6906
31. Samid D., Miller A.C., Rimoldi D.J., Gafner J., and Clark E.P. Increased radiation resistance in transformed and nontransformed cells with elevated ras proto-oncogene expression. Radiat. Res. 126 (1991) 244-250
32. Hermens A., and Bentvelzen P. Influence of the Ha-ras oncogene on radiation response of a rat rhabdomyosarcoma cell line. Cancer Res. 52 (1992) 3073-3082
33. Gupta A.K., Bernhard E.J., Bakanauskas V.J., Wu J.M., Muschel R.J., and McKenna W.G. Ras-mediated radiation resistance is not linked to MAP kinase activation in two bladder carcinoma cell lines. Radiat. Res. 154 (2000) 64-72
34. Caron de Fromentel C., Nardeux P.C., Soussi T., Lavialle C., Estrade S., Carloni G., Chandrasekaran K., and Cassingena R. Epithelial HBL-100 cell line derived from milk of an apparently healthy woman harbours SV40 genetic information. Exp. Cell Res. 160 (1985) 83-94
35. Su L.N., and Little J.B. Prolonged cell cycle delay in radioresistant human cell lines transfected with activated ras oncogene and/or simian virus 40 T-antigen. Radiat. Res. 133 (1993) 73-79
36. Jung M., and Dritschilo A. Modification of the radiosensitivity of human testicular cancer cells by simian virus 40 sequences. Radiat. Res. 140 (1994) 186-190
37. Hofseth L.J., Hussain S.P., Wogan G.N., and Harris C.C. Nitric oxide in cancer and chemoprevention. Free Radic. Biol. Med. 34 (2003) 955-968
38. Lala P.K., and Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 2 (2001) 149-156
39. Lechner M., Lirk P., and Rieder J. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Semin. Cancer Biol. 15 (2005) 277-289
40. Ziche M., and Morbidelli L. Nitric oxide and angiogenesis. J. Neurooncol. 50 (2000) 139-148
41. Leach J.K., Van Tuyle G., Lin P.S., Schmidt-Ullrich R., and Mikkelsen R.B. Ionizing radiation-induced, mitochondria-dependent generation of reactive oxygen/nitrogen. Cancer Res. 61 (2001) 3894-3901
42. Leach J.K., Black S.M., Schmidt-Ullrich R.K., and Mikkelsen R.B. Activation of constitutive nitric-oxide synthase activity is an early signalling event induced by ionising radiation. J. Biol. Chem. 277 (2002) 15400-15406
43. Shao C., Stewart V., Folkard M., Michael B.D., and Prise K.M. Nitric oxide-mediated signalling in the bystander response of individually targeted glioma cells. Cancer Res. 63 (2003) 8437-8442
44. Macnaughton W.K., Aurora A.R., Bhamra J., Sharkey K.A., and Miller M.J.S. Expression, activity and cellular localization of inducible nitric oxide synthase in rat ileum and colon post-irradiation. Int. J. Radiat. Biol. 74 (1998) 255-264
45. Jordan B.F., Beghein N., Aubry M., Grégoire V., and Gallez B. Potentiation of radiation-induced regrowth delay by isosorbide dinitrate in FSAII murine tumors. Int. J. Cancer 103 (2003) 138-141
46. Worthington J., Robson T., O'Keeffe M., and Hirst D.G. Tumour cell radiosensitization using constitutive (CMV) and radiation inducible (WAF1) promoters to drive the iNOS gene: a novel suicide gene therapy. Gene Ther. 9 (2002) 263-269
47. Worthington J., Robson T., Scott S., and Hirst D. Evaluation of a synthetic CarG promoter for nitric oxide synthase gene therapy of cancer. Gene Ther. 12 (2005) 1417-1423